newsfilter
← Latest News
Business Wire·

Aurinia Announces Management Transition

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) announced today that Kevin Tang, Aurinia's Chair of the Board, will succeed Peter Greenleaf as Chief Executive Officer. Peter will continue as a consultant to facilitate the